GDS-15 Calculator

The Geriatric Depression Scale — Short Form (GDS-15) is a 15-item self-report questionnaire designed specifically to screen for depressive symptoms in older adults. Developed by Sheikh and Yesavage in 1986 as a shortened version of the original 30-item Geriatric Depression Scale (GDS-30), the GDS-15 was designed to be simpler and less burdensome for elderly respondents while maintaining clinical utility.

Each item uses a straightforward Yes/No response format, producing a total score between 0 and 15. The GDS-15 was specifically designed for older populations and deliberately excludes somatic symptoms (such as fatigue, appetite changes, and sleep disturbance) that commonly occur in ageing and medical illness and can inflate depression scores on other instruments.

The original 30-item GDS was developed by Yesavage and colleagues in 1982 as the first depression screening instrument designed specifically for older adults. The GDS-15 was subsequently derived by Sheikh and Yesavage (1986) by selecting the 15 items that correlated most strongly with depressive symptoms in validation studies.

The GDS-15 has been extensively validated across diverse older adult populations. Studies consistently report good internal consistency (Cronbach's alpha 0.74-0.86), adequate sensitivity (typically 80-90%) and specificity (typically 70-85%) at standard cut-off points, and strong correlation with the full GDS-30.

A key design feature of the GDS-15 is the exclusion of somatic items. In older adults, physical symptoms such as fatigue, sleep disturbance, and appetite changes are common due to medical conditions and normal ageing, making somatic-heavy depression scales prone to false positives. The GDS-15 focuses on cognitive and affective symptoms of depression, improving its specificity in geriatric populations.

The GDS-15 uses a simple Yes/No response format. Each item is scored 0 or 1, with some items reverse-scored. A response indicating depressive symptoms scores 1; the alternative scores 0.

Total scores range from 0 to 15. Published severity thresholds are:

0-4: Normal, no significant depressive symptoms 5-8: Mild depressive symptoms — further evaluation may be warranted 9-11: Moderate depressive symptoms 12-15: Severe depressive symptoms

A score of 5 or above is commonly used as the threshold for further clinical evaluation. The Yes/No format reduces the cognitive demands on respondents compared to instruments using Likert scales, which is particularly beneficial for older adults or those with mild cognitive impairment.

The GDS-15 is widely used in aged care settings, geriatric medicine, primary care for older adults, and mental health services. Its design features — brief format, Yes/No responses, absence of somatic items — make it particularly suitable for use with medically ill older adults and those in residential aged care.

The instrument can be administered verbally by a practitioner, which supports its use with individuals who have visual impairment or difficulty with written measures. Typical administration time is five to seven minutes.

Depression in older adults is frequently under-recognised, as symptoms may be attributed to normal ageing, grief, or medical illness. Routine screening with the GDS-15 can support earlier identification of depressive symptoms in this population. It is also useful for monitoring symptom changes over time.

In Australia, the GDS-15 is widely used in aged care, general practice, and geriatric specialist settings. It is referenced in clinical guidelines for the assessment of depression in older adults and is used in aged care quality assessment processes.

The instrument is relevant to Australia's ageing population and is used in residential aged care facilities, home care services, hospital geriatric units, and community health centres. Australian research has validated the GDS-15 in local populations, including culturally and linguistically diverse communities.

The GDS-15 supports the aims of the Aged Care Quality Standards, which require providers to address the mental health and emotional wellbeing of older Australians. Its ease of administration and geriatric-specific design make it a practical tool for routine screening in these settings.